S&P ASX All Technology

US Dollar vs AUD

Register to chat with like-minded investors on our interactive forums.

Get Started

ABIO ARCA Biopharma Inc

3.21

0.00 (0.00%)

Pre Market

Last Updated: 18:50:36

Delayed by 15 minutes

ARCA biopharma reports Q3 results

To read the full story on Seeking Alpha, click here.

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more ARCA Biopharma Charts.

ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more ARCA Biopharma Charts.

ARCA Biopharma Inc News

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Saturday 6 April 2024 (2 weeks ago) • PR Newswire (US)

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Wednesday 3 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 8 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

ARCA biopharma Announces 2023 Financial Results
Friday 2 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

More ARCA Biopharma Inc News Articles

Verizon Communications

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions